Cheng Yue について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Yu Chengxiao について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Huang Mingtao について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Du Fangzhi について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Song Ci について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Ma Zijian について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Zhai Xiangjun について
Department of Infectious Diseases, Jiangsu Province Center for Disease Prevention and Control, Nanjing, China について
Yang Yuan について
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China について
Liu Jibin について
Tumor Biobank, Nantong Tumor Hospital, Nantong, China について
Bei Jin-Xin について
Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China について
Jia Weihua について
Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China について
Jin Guangfu について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Li Shengping について
Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China について
Zhou Weiping について
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China について
Liu Jianjun について
Department of Human Genetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore について
Dai Juncheng について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Hu Zhibin について
Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China について
Cancer Epidemiology について
非線形性 について
遺伝 について
喫煙 について
飲酒 について
肝細胞癌 について
患者 について
バイアス について
不均一性 について
性別 について
スコア について
遺伝的リスク について
交絡 について
疫学研究 について
観察研究 について
テロメア長 について
テロメア長 について
肝細胞癌 について
リスク について
遺伝的関連 について
解析 について